StemCell Therapy

DUBLIN--(BUSINESS WIRE)--The "Diabetes Assays (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

This market model discusses in detail the impact of COVID-19 on Diabetes Assays market for the year 2020 and beyond.

Companies Mentioned

Hemoglobin (HbA1c) assays are the most commonly used for both initial and confirmatory screening of diabetes across all geographical regions. The American Diabetes Association (ADA) recommends HbA1c tests 2 times per year in patients who are meeting treatment goals and additional testing for patients who are not meeting their treatment goals. Screening may be repeated every three years in patients that have normal test results.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Diabetes Assays and evolving competitive landscape.

Global, Regional and Country level market specific insights.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Reasons to Buy

The model will enable you to:

For more information about this report visit https://www.researchandmarkets.com/r/awtz02

View post:
Impact of COVID-19 on the Global Diabetes Assays Industry 2020-2030 Featuring Siemens Healthineers, Abbott Labs, Roche, Danaher and Tosoh -...

This entry was posted on August 15, 2020 at 9:47 am and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |